Ajanta Pharma Overview
- Year Founded
-
1973
- Status
-
Public
- Employees
-
13,206
- Stock Symbol
-
532331
- Investments
-
1
- Share Price
-
$34.93
- (As of Friday Closing)
Ajanta Pharma General Information
Description
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
Contact Information
Website
www.ajantapharma.comCorporate Office
- Ajanta House, Charkop
- Kandivli West
- Mumbai, Maharashtra 400067
- India
Corporate Office
- Ajanta House, Charkop
- Kandivli West
- Mumbai, Maharashtra 400067
- India
Ajanta Pharma Stock Performance
As of 13-Nov-2026, Ajanta Pharma’s stock price is $34.93. Its current market cap is $4.36B with 125M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $34.93 | $35.45 | $27.60 - $39.68 | $4.36B | 125M | 12.7K | $1.09 |
Ajanta Pharma Financials Summary
As of 30-Sep-2026, Ajanta Pharma has a trailing 12-month revenue of $670M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 4,664,217 | 3,621,606 | 3,732,236 | 3,326,616 |
| Revenue | 670,477 | 611,932 | 542,533 | 502,693 |
| EBITDA | 202,922 | 171,484 | 154,551 | 148,435 |
| Net Income | 136,200 | 119,506 | 108,848 | 98,588 |
| Total Assets | 668,942 | 652,323 | 586,274 | 556,205 |
| Total Debt | 16,051 | 27,574 | 5,544 | 4,231 |
Ajanta Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ajanta Pharma Comparisons
Industry
Financing
Details
Ajanta Pharma Competitors (32)
One of Ajanta Pharma’s 32 competitors is Torrent Pharmaceuticals, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Corporation | Ahmedabad, India | ||||
| Granules India | Corporation | Hyderabad, India | ||||
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Jubilant Pharmova | Corporation | Noida, India | ||||
| Mankind Pharma | Formerly PE-Backed | New Delhi, India |
Ajanta Pharma Patents
Ajanta Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20100179202-A1 | Orally disintegrating composition of zolmitriptan | Inactive | 14-Jan-2009 | ||
| WO-2009074995-A1 | Taste masked chewable compositions of sildenafil citrate | Inactive | 10-Dec-2007 | ||
| AU-2001284382-A1 | A controlled release anti-inflammatory formulation and a process for the preparation thereof | Inactive | 20-Jun-2000 | ||
| EP-1406635-A2 | A controlled release anti-inflammatory formulation and a process for the preparation thereof | Inactive | 20-Jun-2000 | ||
| WO-2001097775-A2 | Controlled release anti-inflammatory formulation | Inactive | 20-Jun-2000 | A61K9/0065 |
Ajanta Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ajanta Pharma Acquisitions (1)
Ajanta Pharma’s most recent deal was a Merger/Acquisition with CAPS Pharmaceuticals. The deal was made on 05-Apr-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CAPS Pharmaceuticals | 05-Apr-2018 | Merger/Acquisition | Pharmaceuticals |
Ajanta Pharma ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.53 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Ajanta Pharma Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CAPS Pharmaceuticals | Harare, Zimbabwe | 1952 |
Ajanta Pharma FAQs
-
When was Ajanta Pharma founded?
Ajanta Pharma was founded in 1973.
-
Where is Ajanta Pharma headquartered?
Ajanta Pharma is headquartered in Mumbai, India.
-
What is the size of Ajanta Pharma?
Ajanta Pharma has 13,206 total employees.
-
What industry is Ajanta Pharma in?
Ajanta Pharma’s primary industry is Pharmaceuticals.
-
Is Ajanta Pharma a private or public company?
Ajanta Pharma is a Public company.
-
What is Ajanta Pharma’s stock symbol?
The ticker symbol for Ajanta Pharma is 532331.
-
What is the current stock price of Ajanta Pharma?
As of 13-Nov-2026 the stock price of Ajanta Pharma is $34.93.
-
What is the current market cap of Ajanta Pharma?
The current market capitalization of Ajanta Pharma is $4.36B.
-
What is Ajanta Pharma’s current revenue?
The trailing twelve month revenue for Ajanta Pharma is $670M.
-
Who are Ajanta Pharma’s competitors?
Torrent Pharmaceuticals, Granules India, Glenmark Pharmaceuticals, Jubilant Pharmova, and Mankind Pharma are some of the 32 competitors of Ajanta Pharma.
-
What is Ajanta Pharma’s annual earnings per share (EPS)?
Ajanta Pharma’s EPS for 12 months was $1.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
